Medicare Enrolled
Dr. Faiz Bhora, M.D.,
Surgery · Poughkeepsie, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bhora from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhora?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bhora
Dr. Faiz Bhora is a surgery specialist in Poughkeepsie, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bhora performed 469 Medicare services across 382 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bhora received a total of $252,370 from 56 pharmaceutical and/or device companies across 399 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bhora is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 19% volume in NY
$252,370 industry payments
Medicare Practice Summary
Medicare Utilization ↗469
Medicare services
Top 19% in NY for surgery
382
Unique beneficiaries
$152
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~23 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
145 | $159 | $607 |
| New patient office visit, complex (60-74 min) | 99 | $191 | $743 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $109 | $434 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
38 | $40 | $957 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $69 | $243 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $152 | $635 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
21 | $10 | $900 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
14 | $183 | $4,812 |
| Initial removal of wedge of lung tissue using an endoscope A surgical procedure to remove a small, wedge-shaped section of lung tissue using an endoscope. This minimally invasive technique allows for tissue sampling or removal without large incisions. |
14 | $653 | $2,893 |
| Endoscopic removal of chest lymph nodes A surgical procedure to remove lymph nodes from the chest cavity using an endoscope, a thin tube with a camera inserted through small incisions. |
12 | $183 | $694 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
12 | $104 | $349 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$252,370
Total received (2018-2024)
Avg $36,053/year across 7 years
Top 1% in NY for surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
399
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$145,168 (57.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$81,489 (32.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,371 (10.1%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$343 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$48,111
2023
$56,955
2022
$33,767
2021
$28,696
2020
$10,131
2019
$44,352
2018
$30,358
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$35,354
Elucent Medical
$3,800
E.R. Squibb & Sons, L.L.C.
$3,281
Medical Device Business Services, Inc.
$2,145
Noah Medical Corporation
$1,028
Ambu Inc.
$360
Boston Scientific Corporation
$319
INTUITIVE SURGICAL, INC.
$242
Medtronic, Inc.
$199
Dilon Technologies, Inc.
$198
Ethicon US, LLC
$166
Pulmonx Corporation
$154
Seapearl East, Inc
$139
Galvanize Therapeutics, Inc
$137
Davol Inc.
$136
Ethicon Endo-Surgery Inc.
$125
Inspire Medical Systems, Inc.
$73
Pinnacle Biologics, Inc
$54
ATRICURE, INC.
$43
Regeneron Healthcare Solutions, Inc.
$41
United Therapeutics Corporation
$30
Becton, Dickinson and Company
$23
TELA Bio, Inc.
$18
Merck Sharp & Dohme LLC
$16
Pacira Pharmaceuticals Incorporated
$16
Siemens Medical Solutions USA, Inc.
$13
Top 3 companies account for 88.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$59,459
Boston Scientific Corporation
$54,807
Veran Medical Technologies, Inc.
$39,047
BOSTON SCIENTIFIC CORPORATION
$27,630
Medical Device Business Services, Inc.
$15,030
Ambu Inc.
$10,725
Ethicon US, LLC
$7,479
Intuitive Surgical, Inc.
$5,701
Genentech USA, Inc.
$4,269
Elucent Medical
$4,000
Ethicon Inc.
$3,749
E.R. Squibb & Sons, L.L.C.
$3,281
Noah Medical Corporation
$1,941
Pulmonx Corporation
$1,681
Davol Inc.
$1,646
Covidien LP
$1,580
Synthes USA Products LLC
$1,509
Medtronic, Inc.
$1,251
Becton, Dickinson and Company
$761
Auris Health, Inc.
$730
Galvanize Therapeutics, Inc
$554
Merit Medical Systems Inc
$466
DePuy Synthes Sales Inc.
$430
Olympus America Inc.
$400
Dilon Technologies, Inc.
$345
Endogastric Solutions, Inc
$336
Innocoll Pharmaceuticals Limited
$325
Bard Access Systems, Inc.
$260
INTUITIVE SURGICAL, INC.
$242
GE HealthCare
$212
Lexington Medical, Inc.
$198
CONMED Corporation
$174
Inspire Medical Systems, Inc.
$173
Ethicon Endo-Surgery Inc.
$160
ATRICURE, INC.
$152
AtriCure, Inc.
$147
DAVOL INC.
$146
Seapearl East, Inc
$139
Activ Surgical, Inc.
$137
Foundation Medicine, Inc.
$132
Body Vision Medical Inc.
$130
CSA Medical, Inc
$129
KLS-Martin L.P.
$117
Biom'Up France SAS
$107
Surgical Theater. Inc.
$97
Pinnacle Biologics, Inc
$96
Siemens Medical Solutions USA, Inc.
$68
Regeneron Healthcare Solutions, Inc.
$41
Surgical Specialties Corporation (US), Inc.
$36
Zimmer Biomet Holdings, Inc.
$30
United Therapeutics Corporation
$30
Chiesi USA, Inc.
$21
TELA Bio, Inc.
$18
Merck Sharp & Dohme LLC
$16
Pacira Pharmaceuticals Incorporated
$16
PharmaEssentia USA Corporation
$14
Top 3 companies account for 60.7% of all-time payments
Associated products mentioned in payments ›
ACQUIRE · AERO Stent and Delivery System · AIRSEAL · ALIYA SYSTEM · ARISTA AH · ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) · ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM · AUGTYRO · Acquire · ActivSight · Aeon Endostapler & Echelon Flex Powered Stapler · Agile Esophageal · BESREMI · CAPTIVATOR · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHARTIS CATHETER · CLEVIPREX · CONMED HEMOSTASIS · CONTOUR · CRE · Cios Spin · DYNAMIC · Da Vinci Surgical System · ECHELON ENDOPATH · ECHELON FLEX Stapler · ENDO GIA ULTRA · ESOPHYX · EVARREST · EVICEL · EVIS EXERA · EVIS EXERA II ULTRASONIC BRONCHOFIBERVIDEOSCOPE · EXALT · EXALT Model D · EXPECT · Echelon Flex · Echelon; Endopath · EleVision · Endo GIA · Enseal · Exparel · FOUNDATIONONE · FOUNDATIONONE CDX · GALAXY · GENERAL PULMONARY · GENERAL PULMONARY · GENERAL THERAPIES · GENERAL - BRONCHIAL THERMOPLASTY · GENERAL - PULMONARY · GENERAL - THERAPIES · GENERAL PULMONARY · General - Pulmonary · HARMONIC Product Family · HEMOBLAST BELLOWS · ILLUMISITE · IMFINZI · INSPIRE · ION · KEYTRUDA · LIBTAYO · LIGASURE · LINX Reflux Management System · MATRIXRIB · MICROLAP · MONARCH · Monarch Platform · NA · OPDIVO · ORENITRAM · Olympus EBUS Bronchoscopes · OviTex 2S · PREZCOBIX · PROGEL · Phasix Mesh · Photofrin · Progel · Progel Applicator Spray Tips · REMODULIN · RESOLUTION CLIP · RIBFIX BLU ADVANTAGE · SIGNIA · SURGIFLO Hemostatic Matrix Family of Products · Spin · Surgical wound closure product · TAGRISSO · TECENTRIQ · THERAPIES · THORACOPORT · TIO · TIO Oral Airway Bite Block · ULTRAFLEX · WallFlex Duodenal · XARACOLL · ZEPHYR ENDOBRONCHIAL VALVE · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in surgery and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for surgery in NY.
Geographic Context
Surgerists within 10 mi
58
Per 100K population
19.5
County median income
$97,273
Nearest hospital
VASSAR BROTHERS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bhora is a clinical cardiology specialist, with above-average Medicare volume (top 19% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bhora experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Bhora performed 145 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bhora receive payments from pharmaceutical companies?
Yes. Dr. Bhora received a total of $252,370 from 56 companies across 399 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhora's costs compare to other surgerists in Poughkeepsie?
Dr. Bhora's average Medicare payment per service is $152. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhora) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Surgerists in Poughkeepsie
Browse surgerists in Poughkeepsie ranked by procedure volume and transparency data.
Highest volume
Top Surgerists in NY
Surgerists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Surgerists in NY
Which NY surgerists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Veran Medical Technologies, Inc. Payments to Doctors
See all physicians who received payments from Veran Medical Technologies, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology